Thread: Spheramine(R): did not meet Phase IIb study's primary or key sec endpoints
View Single Post
Old 07-02-2008, 07:47 AM
jeanb's Avatar
jeanb jeanb is offline
Senior Member
  
Join Date: Aug 2006
Location: sonoran desert
Posts: 1,352
15 yr Member
jeanb jeanb is offline
Senior Member
jeanb's Avatar
 
Join Date: Aug 2006
Location: sonoran desert
Posts: 1,352
15 yr Member
Exclamation Spheramine(R): did not meet Phase IIb study's primary or key sec endpoints
Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
07.02.08, 7:01 AM ET


Titan Pharmaceuticals, Inc. (AMEX:TTP) today announced initial analyses show that Spheramine(R) did not meet the Phase IIb clinical study's primary or key secondary endpoints, with no significant differences detected between the Spheramine and sham surgery arms of the study after 12 months of follow-up.

read the full article:
http://www.forbes.com/businesswire/f...2005205r1.html
__________________
Jean B

This isn't the life I wished for, but it is the life I have. So I'm doing my best.
jeanb is offline   Reply With QuoteReply With Quote